Skip to content

The Travelers Companies

US · TRV #295 by market cap Listed 1991
393.24 +2.63 +0.67%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    UBS Maintains The Travelers Companies(TRV.US) With Hold Rating, Maintains Target Price $383
    Market Newswire · 2026/9/29
  • The Travelers Companies(TRV.US) Officer Sells US$6.1 Million in Common Stock
    Market Newswire · 2026/11/7
  • Rating change
    BofA Securities Maintains The Travelers Companies(TRV.US) With Sell Rating
    Market Newswire · 2026/10/1
  • Rating change
    KBW Maintains The Travelers Companies(TRV.US) With Hold Rating, Cuts Target Price to $372
    Market Newswire · 2026/10/12
  • Rating change
    Roth MKM Maintains The Travelers Companies(TRV.US) With Buy Rating, Raises Target Price to $460
    Market Newswire · 2026/10/26
  • Company notice
    IA CLARINGTON INVESTMENTS INC STRATEGIC CORPORATE BD FD ETF SER TR UNI: INTERIM MANAGEMENT REPORT OF FUND PERFORMANCE EN
    SEDAR · 2026/11/21
  • Rating change
    Analysts Offer Insights on Financial Companies: Travelers Companies (TRV) and Corebridge Financial, Inc. (CRBG)
    TipRanks · 2026/9/28
  • UBS Maintains The Travelers Companies(TRV.US) With Hold Rating, Maintains Target Price $405
    Market Newswire · 2026/10/20
  • Company notice
    STRATEGIC STUDENT & SENIOR HUSNG TR | 8-K: Current report
    SEC · 2026/11/21
  • Rating change
    Piper Sandler Maintains The Travelers Companies(TRV.US) With Buy Rating, Raises Target Price to $405
    Market Newswire · 2026/9/28
  • Rating change
    A Quick Look at Today's Ratings for The Travelers Companies(TRV.US), With a Forecast Between $318 to $378
    Market Newswire · 2026/10/7
  • A Quick Look at Today's Ratings for The Travelers Companies(TRV.US), With a Forecast Between $318 to $450
    Market Newswire · 2026/10/20
  • Rating change
    Morgan Stanley Maintains The Travelers Companies(TRV.US) With Sell Rating, Maintains Target Price $330
    Market Newswire · 2026/10/20
  • Company notice
    IA CLARINGTON INVESTMENTS INC WEALTH ENHANCED BD POOL ETF SER TR UNIT: INTERIM MANAGEMENT REPORT OF FUND PERFORMANCE EN
    SEDAR · 2026/11/21
  • Company notice
    IA CLARINGTON INVESTMENTS INC WEALTH ENHANCED BD POOL ETF SER TR UNIT: INTERIM MANAGEMENT REPORT OF FUND PERFORMANCE FR
    SEDAR · 2026/11/21
  • Rating change
    Morgan Stanley Maintains The Travelers Companies(TRV.US) With Sell Rating, Raises Target Price to $350
    Market Newswire · 2026/10/23
  • A Quick Look at Today's Ratings for The Travelers Companies(TRV.US), With a Forecast Between $318 to $435
    Market Newswire · 2026/10/19
  • Company notice
    IA CLARINGTON INVESTMENTS INC STRATEGIC CORPORATE BD FD ETF SER TR UNI: INTERIM MANAGEMENT REPORT OF FUND PERFORMANCE FR
    SEDAR · 2026/11/21
  • Rating change
    BofA Securities Maintains The Travelers Companies(TRV.US) With Sell Rating, Announces Target Price $320
    Market Newswire · 2026/10/12
  • Citi Maintains The Travelers Companies(TRV.US) With Hold Rating, Raises Target Price to $395
    Market Newswire · 2026/10/17
  • Form 144 | The Travelers Companies(TRV.US) Officer Proposes to Sell 4.33 Million in Common Stocks
    Market Newswire · 2026/10/28
  • Rating change
    BMO Capital Maintains The Travelers Companies(TRV.US) With Hold Rating, Maintains Target Price $379
    Market Newswire · 2026/9/23
  • Form 144 | The Travelers Companies(TRV.US) Officer Proposes to Sell 6.1 Million in Common Stocks
    Market Newswire · 2026/11/5
  • The Travelers Companies(TRV.US) Officer Sells US$4.33 Million in Common Stock
    Market Newswire · 2026/10/29
  • Company notice
    Enhua Pharmaceutical: Announcement that the licensor\'s TRV-130 injection marketing application has been approved by the FDA
    SZSI · 2020/8/11

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

The Travelers Companies discussion 0 comments

Add a comment